MMP9 Rekombinanter Antikörper
MMP9 Rekombinant Antikörper für FC (Intra)
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
Maus
Anwendung
FC (Intra)
Konjugation
Unkonjugiert
CloneNo.
230069F1
Kat-Nr. : 98396-1-RR
Synonyme
Geprüfte Anwendungen
| Erfolgreiche Detektion in FC (Intra) | mit LPS und Brefeldin A behandelte RAW 264.7-Zellen |
Empfohlene Verdünnung
| Anwendung | Verdünnung |
|---|---|
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Produktinformation
98396-1-RR bindet in FC (Intra) MMP9 und zeigt Reaktivität mit Maus
| Getestete Reaktivität | Maus |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | MMP9 fusion protein Eg0452 |
| Vollständiger Name | matrix metallopeptidase 9 |
| Berechnetes Molekulargewicht | 81kd |
| GenBank-Zugangsnummer | NM_013599 |
| Gene symbol | Mmp9 |
| Gene ID (NCBI) | 17395 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein A purfication |
| Lagerungspuffer | PBS with 0.09% sodium azide |
| Lagerungsbedingungen | Store at 2 - 8°C. Stable for one year after shipment. |
Hintergrundinformationen
MMP9 (matrix metallopeptidase 9), also named as Gelatinase B, is a member of matrix metalloproteinase (MMP) family. The MMP family of enzymes is comprised of critically important extracellular matrix remodeling proteases whose activity has been implicated in normal embryogenesis, tissue remodelling and many diseases such as arthritis, cancer, periodontitis, glomerulonephritis, encephalomyelitis, atherosclerosis and tissue ulceration. MMP9 is produced by a variety of normal and transformed cells including neutrophils, monocytes, macrophages, astrocytes, fbroblasts, osteoclasts and so on. Transgenic mouse models report that MMP9 contributes to skin carcinogenesis, suppresses development of experimental abdominal aortic aneurysms, and triggers the angiogenic switch during carcinogenesis.
Protokolle
| PRODUKTSPEZIFISCHE PROTOKOLLE | |
|---|---|
| FC protocol for MMP9 antibody 98396-1-RR | Download protocol |
| STANDARD-PROTOKOLLE | |
|---|---|
| Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |


